Bellevue Life Sciences Acquisition (BLAC) News Today $11.60 -0.07 (-0.60%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Bellevue Life Sciences Acquisition Corp trading halted, volatility trading pauseNovember 15, 2024 | markets.businessinsider.comBellevue Life Sciences Acquisition Corp trading resumesNovember 15, 2024 | markets.businessinsider.comBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Shares Sold by Berkley W R CorpBerkley W R Corp lessened its holdings in shares of Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Free Report) by 69.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 99,358 shares of the company's stock after selling 223,332 shares during the quarSeptember 24, 2024 | marketbeat.comBellevue Life Sciences Acquisition (BLAC)September 20, 2024 | investing.comBellevue video game company faces class-action lawsuit over antitrust practicesAugust 14, 2024 | bizjournals.comBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Sees Significant Decrease in Short InterestBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Get Free Report) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 100 shares, a drop of 92.3% from the April 30th total of 1,300 shares. Based on an average daily trading volume, of 22,600 shares, the short-interest ratio is currently 0.0 days.May 28, 2024 | marketbeat.comMizuho Securities USA LLC Invests $1.39 Million in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC)Mizuho Securities USA LLC acquired a new stake in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 133,495 shares of the company's stock, valued at approximMay 19, 2024 | marketbeat.comBellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder MeetingMay 13, 2024 | prnewswire.comShort Interest in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Increases By 46.7%Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Get Free Report) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 2,200 shares, a growth of 46.7% from the March 31st total of 1,500 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 23,800 shares, the short-interest ratio is presently 0.1 days.April 27, 2024 | marketbeat.comSchechter Investment Advisors LLC Raises Stock Position in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC)Schechter Investment Advisors LLC increased its stake in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Free Report) by 84.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 211,227 shares of the company's stock afMarch 27, 2024 | marketbeat.comBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Short Interest Up 27.3% in FebruaryBellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Get Free Report) saw a significant growth in short interest in February. As of February 29th, there was short interest totalling 1,400 shares, a growth of 27.3% from the February 14th total of 1,100 shares. Based on an average daily trading volume, of 14,000 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are sold short.March 15, 2024 | marketbeat.comWolverine Asset Management LLC Grows Stake in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC)Wolverine Asset Management LLC increased its position in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Free Report) by 40.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 173,110 shares of the company's stockFebruary 18, 2024 | marketbeat.comCommonwealth of Pennsylvania Public School Empls Retrmt SYS Has $2.30 Million Position in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC)Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC - Free Report) by 82.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investorFebruary 15, 2024 | marketbeat.comBellevue Life Sciences Acquisition Corp.April 21, 2023 | wsj.comBLACW Bellevue Life Sciences Acquisition Corp. WT EXP 020928April 18, 2023 | seekingalpha.com Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Missed Nvidia? Watch this ASAP (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket. Click here and I’ll tell you everything you need to know. BLAC Media Mentions By Week BLAC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLAC News Sentiment▼0.001.11▲Average Unclassified News Sentiment BLAC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLAC Articles This Week▼20▲BLAC Articles Average Week Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SONX News Today SKIN News Today BWAY News Today ZJYL News Today KRMD News Today NVRO News Today DRTS News Today LAKE News Today PDEX News Today SRTS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLAC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
